IASO Biotechnology Partners with Instituto Butantan to Localise CAR-T Therapy in Brazil
IASO Bio licenses CAR-T technology to Instituto Butantan for local development in Brazil, aiming to reduce treatment costs and expand public access to advanced therapies for haematological cancer patients.
Advanced Therapies | 13/04/2026 | By News Bureau
Sun Pharma Launches Semaglutide Injection in India Under Noveltreat and Sematrinity
Sun Pharmaceutical Industries has introduced semaglutide injections in India under the brands Noveltreat and Sematrinity, expanding access to advanced therapies for chronic weight management and type 2 diabetes. The launch strengthens treatment options with multiple dose strengths tailored to patient needs alongside diet and lifestyle interventions.
Advanced Therapies | 21/03/2026 | By News Bureau | 334
The global biologics and biosimilars market is expected to reach approximately USD 600 billion by 2032, expanding at a compound annual growth rate (CAGR) of around 6.33 percent during the forecast period.
Advanced Therapies | 15/07/2025 | By Dineshwori | 155
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy